Concepedia

Andrew McGown

AM

Statistics

Publications

17

Citations

1.1K

H-Index

14

Active since

1993

Affiliations

The Christie Hospital(Current)

University of Sussex

Cancer Research UK

University of Southampton

Cancer Research UK Manchester Institute

Andrew McGown is an author at The Christie Hospital specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1993–2024

17

Publications

17

Molecular Imaging and Biological Evaluation of HuMV833 Anti-VEGF Antibody: Implications for Trial Design of Antiangiogenic Antibodies

Gordon C. Jayson, Jamal Zweit, Alan Jackson et al. · JNCI Journal of the National Cancer Institute · 2002 · 257 citations · Full text

, , +16

In vivo and in vitro evaluation of combretastatin A-4 and its sodium phosphate prodrug

Konstantina Grosios, S E Holwell, Andrew McGown et al. · British Journal of Cancer · 1999 · 213 citations · Full text

, , +9

A phase I study of intravenous bryostatin 1 in patients with advanced cancer

J Prendiville, D. Crowther, Nicholas Thatcher et al. · British Journal of Cancer · 1993 · 145 citations · Full text

, , +7

5T4 oncofetal antigen expression in ovarian carcinoma

E. Wrigley, Andrew McGown, John Rennison et al. · International Journal of Gynecological Cancer · 1995 · 89 citations

, , +17

Metallodrug Profiling against SARS‐CoV‐2 Target Proteins Identifies Highly Potent Inhibitors of the S/ACE2 interaction and the Papain‐like Protease PL<sup>pro</sup>

María Gil‐Moles, Sebastian Türck, Uttara Basu et al. · Chemistry - A European Journal · 2021 · 75 citations · Full text

, , +16

1–5 of 17